Stephanie Watts - Publications

Affiliations: 
Biochemistry and Molecular Biology Michigan State University, East Lansing, MI 
Area:
Biochemistry

109 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Miron TR, Flood ED, Tykocki NR, Thompson JM, Watts SW. Identification of Piezo1 channels in perivascular adipose tissue (PVAT) and their potential role in vascular function. Pharmacological Research. 175: 105995. PMID 34818570 DOI: 10.1016/j.phrs.2021.105995  0.754
2021 Seitz BM, Watts SW, Fink GD. Reduction in Hindquarter Vascular Resistance Supports 5-HT Receptor Mediated Hypotension. Frontiers in Physiology. 12: 679809. PMID 34248666 DOI: 10.3389/fphys.2021.679809  0.326
2021 Gonzalez-Pons R, McRae K, Thompson JM, Watts SW. The 5-HT7 receptor restrains 5-HT-induced 5-HT2A mediated contraction in the isolated abdominal vena cava. Journal of Cardiovascular Pharmacology. PMID 34029269 DOI: 10.1097/FJC.0000000000001057  0.303
2021 Orr AN, Thompson JM, Lyttle JM, Watts SW. Transglutaminases Are Active in Perivascular Adipose Tissue. International Journal of Molecular Sciences. 22. PMID 33808023 DOI: 10.3390/ijms22052649  0.313
2020 Contreras GA, Yang Y, Flood ED, Garver H, Bhattacharya S, Fink GD, Watts SW. Blood pressure changes PVAT function and transcriptome: use of the mid-thoracic aorta coarcted rat. American Journal of Physiology. Heart and Circulatory Physiology. PMID 33006918 DOI: 10.1152/ajpheart.00332.2020  0.321
2020 Flood ED, Watts SW. Endogenous Chemerin from PVAT Amplifies Electrical Field-Stimulated Arterial Contraction: Use of the Chemerin Knockout Rat. International Journal of Molecular Sciences. 21. PMID 32887510 DOI: 10.3390/ijms21176392  0.345
2020 Kumar RK, Watts S. IL‐10 Neither Causes Direct Vasorelaxation Nor Reduces Vasoconstriction in Rat Mesenteric Resistance Arteries The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.09011  0.418
2019 Phan HTN, Jackson WF, Shaw V, Watts SW, Neubig RR. Loss-of-function mutations in human RGS2 differentially regulate pharmacological reactivity of resistance vasculature. Molecular Pharmacology. PMID 31645376 DOI: 10.1124/mol.119.116822  0.569
2019 Seitz BM, Demireva EY, Xie H, Fink GD, Krieger-Burke T, Burke WM, Watts SW. 5-HT does not lower blood pressure in the 5-HT knock-out rat. Physiological Genomics. PMID 31125292 DOI: 10.1152/Physiolgenomics.00031.2019  0.337
2019 Demireva EY, Xie H, Flood ED, Thompson JM, Seitz BM, Watts SW. Creation of the 5-hydroxytryptamine receptor 7 knockout (5-HTKO) Rat as a Tool for Cardiovascular Research. Physiological Genomics. PMID 31125290 DOI: 10.1152/physiolgenomics.00030.2019  0.312
2019 Seitz B, Fink G, Watts S. Abstract P3048: The 5-ht 7 Receptor is Essential for 5-ht-Induced Hypotension in the Doca Salt Hypertensive Rat Hypertension. 74. DOI: 10.1161/Hyp.74.Suppl_1.P3048  0.432
2019 Weber P, Flood E, Thompson J, Watts S. Abstract P172: Is the Elastin Receptor Complex a Bridge Between Perivascular Adipose Tissue and the Artery? Hypertension. 74. DOI: 10.1161/Hyp.74.Suppl_1.P172  0.344
2017 Seitz BM, Orer H, Krieger-Burke T, Darios ES, Thompson JM, Fink GD, Watts SW. 5-HT causes splanchnic venodilation. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00165.2017. PMID 28626072 DOI: 10.1152/Ajpheart.00165.2017  0.313
2016 Ferland DJ, Darios ES, Neubig RR, Sjögren B, Truong N, Torres R, Dexheimer TS, Thompson JM, Watts SW. Chemerin-induced arterial contraction is Gi- and calcium-dependent. Vascular Pharmacology. PMID 27890480 DOI: 10.1016/j.vph.2016.11.009  0.31
2016 Watts SW. 2016 Experimental Biology Berne Lecture. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00538.2016. PMID 27663771 DOI: 10.1152/ajpheart.00538.2016  0.302
2016 Darios ES, Winner BM, Charvat T, Krasinski A, Punna S, Watts SW. The adipokine chemerin amplifies electrical field stimulated contraction in the isolated rat superior mesenteric artery. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00998.2015. PMID 27371688 DOI: 10.1152/Ajpheart.00998.2015  0.332
2015 Ayala-Lopez N, Jackson WF, Burnett R, Wilson JN, Thompson JM, Watts SW. Organic Cation Transporter 3 Contributes to Norepinephrine Uptake into Perivascular Adipose Tissue. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00308.2015. PMID 26432838 DOI: 10.1152/ajpheart.00308.2015  0.541
2015 Young LW, Darios ES, Watts SW. An immunohistochemical analysis of SERT in the blood-brain barrier of the male rat brain. Histochemistry and Cell Biology. 144: 321-9. PMID 26223876 DOI: 10.1007/s00418-015-1343-1  0.307
2015 Darios ES, Barman SM, Orer HS, Morrison SF, Davis RP, Seitz BM, Burnett R, Watts SW. 5-Hydroxytryptamine does not reduce sympathetic nerve activity or neuroeffector function in the splanchnic circulation. European Journal of Pharmacology. 754: 140-7. PMID 25732865 DOI: 10.1016/j.ejphar.2015.02.032  0.31
2015 Jespersen B, Tykocki NR, Watts SW, Cobbett PJ. Measurement of smooth muscle function in the isolated tissue bath-applications to pharmacology research. Journal of Visualized Experiments : Jove. 52324. PMID 25650585 DOI: 10.3791/52324  0.702
2015 Petersen-Jones HG, Johnson KB, Hitomi K, Tykocki NR, Thompson JM, Watts SW. Transglutaminase activity is decreased in large arteries from hypertensive rats compared with normotensive controls. American Journal of Physiology. Heart and Circulatory Physiology. 308: H592-602. PMID 25599570 DOI: 10.1152/Ajpheart.00402.2014  0.767
2015 Young L, Darios E, Watts S. SERT and the Blood-Brain Barrier: An In-Depth Analysis of the Male Rat Brain The Faseb Journal. 29. DOI: 10.1096/Fasebj.29.1_Supplement.834.1  0.39
2014 Penumatsa K, Abualkhair S, Wei L, Warburton R, Preston I, Hill NS, Watts SW, Fanburg BL, Toksoz D. Tissue transglutaminase promotes serotonin-induced AKT signaling and mitogenesis in pulmonary vascular smooth muscle cells. Cellular Signalling. 26: 2818-25. PMID 25218191 DOI: 10.1016/j.cellsig.2014.09.002  0.324
2014 Ni W, Watts SW, Ng M, Chen S, Glenn DJ, Gardner DG. Elimination of vitamin D receptor in vascular endothelial cells alters vascular function. Hypertension. 64: 1290-8. PMID 25201890 DOI: 10.1161/Hypertensionaha.114.03971  0.431
2014 Ayala-Lopez N, Martini M, Jackson WF, Darios E, Burnett R, Seitz B, Fink GD, Watts SW. Perivascular adipose tissue contains functional catecholamines. Pharmacology Research & Perspectives. 2: e00041. PMID 24904751 DOI: 10.1002/Prp2.41  0.353
2014 Tykocki NR, Wu B, Jackson WF, Watts SW. Divergent signaling mechanisms for venous versus arterial contraction as revealed by endothelin-1. Journal of Vascular Surgery. PMID 24726828 DOI: 10.1016/J.Jvs.2014.03.010  0.79
2013 Watts SW, Dorrance AM, Penfold ME, Rourke JL, Sinal CJ, Seitz B, Sullivan TJ, Charvat TT, Thompson JM, Burnett R, Fink GD. Chemerin connects fat to arterial contraction. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 1320-8. PMID 23559624 DOI: 10.1161/Atvbaha.113.301476  0.333
2013 Davis RP, Szasz T, Garver H, Burnett R, Tykocki NR, Watts SW. One-month serotonin infusion results in a prolonged fall in blood pressure in the deoxycorticosterone acetate (DOCA) salt hypertensive rat. Acs Chemical Neuroscience. 4: 141-8. PMID 23336053 DOI: 10.1021/Cn300114A  0.762
2013 Tykocki NR, Thompson JM, Jackson WF, Watts SW. Ryanodine receptors are uncoupled from contraction in rat vena cava. Cell Calcium. 53: 112-9. PMID 23177664 DOI: 10.1016/J.Ceca.2012.10.006  0.707
2012 Tykocki NR, Jackson WF, Watts SW. Reverse-mode Na+/Ca2+ exchange is an important mediator of venous contraction. Pharmacological Research. 66: 544-54. PMID 22974823 DOI: 10.1016/J.Phrs.2012.08.004  0.754
2012 Davis RP, Pattison J, Thompson JM, Tiniakov R, Scrogin KE, Watts SW. 5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved. Bmc Pharmacology. 12: 4. PMID 22559843 DOI: 10.1186/1471-2210-12-4  0.398
2011 Patrick Davis R, Linder AE, Watts SW. Lack of the serotonin transporter (SERT) reduces the ability of 5-hydroxytryptamine to lower blood pressure. Naunyn-Schmiedeberg's Archives of Pharmacology. 383: 543-6. PMID 21448568 DOI: 10.1007/s00210-011-0622-1  0.308
2011 Linder AE, Davis RP, Burnett R, Watts SW. Comparison of the function of the serotonin transporter in the vasculature of male and female rats. Clinical and Experimental Pharmacology & Physiology. 38: 314-22. PMID 21371073 DOI: 10.1111/j.1440-1681.2011.05504.x  0.311
2011 Ren W, Watts SW, Fanburg BL. Serotonin transporter interacts with the PDGFβ receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells. American Journal of Physiology. Lung Cellular and Molecular Physiology. 300: L486-97. PMID 21186266 DOI: 10.1152/ajplung.00237.2010  0.302
2010 Johnson KB, Thompson JM, Watts SW. Modification of proteins by norepinephrine is important for vascular contraction. Frontiers in Physiology. 1: 131. PMID 21423373 DOI: 10.3389/fphys.2010.00131  0.303
2010 Northcott CA, Watts S, Chen Y, Morris M, Chen A, Haywood JR. Adenoviral inhibition of AT1a receptors in the paraventricular nucleus inhibits acute increases in mean arterial blood pressure in the rat. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 299: R1202-11. PMID 20702798 DOI: 10.1152/Ajpregu.00764.2009  0.71
2010 Tykocki NR, Watts SW. The interdependence of endothelin-1 and calcium: a review. Clinical Science (London, England : 1979). 119: 361-72. PMID 20662769 DOI: 10.1042/Cs20100145  0.694
2010 Szasz T, Watts SW. Uric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats. The Journal of Pharmacology and Experimental Therapeutics. 333: 758-63. PMID 20215410 DOI: 10.1124/jpet.109.160184  0.342
2009 Szasz T, Eddy S, Paulauskis J, Burnett R, Ellekilde M, Iovanna JL, Watts SW. Differential expression of pancreatitis-associated protein and thrombospondins in arterial versus venous tissues. Journal of Vascular Research. 46: 551-60. PMID 19571575 DOI: 10.1159/000226223  0.307
2009 Watts SW, Priestley JR, Thompson JM. Serotonylation of vascular proteins important to contraction. Plos One. 4: e5682. PMID 19479059 DOI: 10.1371/journal.pone.0005682  0.323
2009 Tykocki NR, Gariepy CE, Watts SW. Endothelin ET(B) receptors in arteries and veins: multiple actions in the vein. The Journal of Pharmacology and Experimental Therapeutics. 329: 875-81. PMID 19297422 DOI: 10.1124/Jpet.108.145953  0.747
2008 Li M, Dai X, Watts S, Kreulen D, Fink G. Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 295: R1546-54. PMID 18768769 DOI: 10.1152/Ajpregu.00783.2007  0.396
2008 Ni W, Zhou H, Diaz J, Murphy DL, Haywood JR, Watts SW. Lack of the serotonin transporter does not prevent mineralocorticoid hypertension in rat and mouse. European Journal of Pharmacology. 589: 225-7. PMID 18573249 DOI: 10.1016/J.Ejphar.2008.06.012  0.5
2008 Thakali K, Galligan JJ, Fink GD, Gariepy CE, Watts SW. Pharmacological endothelin receptor interaction does not occur in veins from ET(B) receptor deficient rats. Vascular Pharmacology. 49: 6-13. PMID 18485831 DOI: 10.1016/J.Vph.2008.03.005  0.696
2008 Ni W, Geddes TJ, Priestley JR, Szasz T, Kuhn DM, Watts SW. The existence of a local 5-hydroxytryptaminergic system in peripheral arteries. British Journal of Pharmacology. 154: 663-74. PMID 18414394 DOI: 10.1038/Bjp.2008.111  0.53
2008 Linder AE, Ni W, Szasz T, Burnett R, Diaz J, Geddes TJ, Kuhn DM, Watts SW. A serotonergic system in veins: serotonin transporter-independent uptake. The Journal of Pharmacology and Experimental Therapeutics. 325: 714-22. PMID 18322152 DOI: 10.1124/Jpet.107.135699  0.504
2008 Diaz J, Ni W, Thompson J, King A, Fink GD, Watts SW. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. The Journal of Pharmacology and Experimental Therapeutics. 325: 1031-8. PMID 18305011 DOI: 10.1124/Jpet.108.136226  0.583
2008 Linder AE, Diaz J, Ni W, Szasz T, Burnett R, Watts SW. Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat. American Journal of Physiology. Heart and Circulatory Physiology. 294: H1745-52. PMID 18263707 DOI: 10.1152/Ajpheart.91415.2007  0.584
2007 Watts SW, Thakali K, Smark C, Rondelli C, Fink GD. Big ET-1 processing into vasoactive peptides in arteries and veins. Vascular Pharmacology. 47: 302-12. PMID 17904426 DOI: 10.1016/J.Vph.2007.08.006  0.697
2007 Linder AE, Ni W, Diaz JL, Szasz T, Burnett R, Watts SW. Serotonin (5-HT) in veins: not all in vain. The Journal of Pharmacology and Experimental Therapeutics. 323: 415-21. PMID 17671100 DOI: 10.1124/Jpet.107.122630  0.527
2007 Fink G, Li M, Lau Y, Osborn J, Watts S. Chronic activation of endothelin B receptors: new model of experimental hypertension. Hypertension. 50: 512-8. PMID 17664390 DOI: 10.1161/Hypertensionaha.107.094821  0.477
2007 Linder AE, Thakali KM, Thompson JM, Watts SW, Webb RC, Leite R. Methyl-beta-cyclodextrin prevents angiotensin II-induced tachyphylactic contractile responses in rat aorta. The Journal of Pharmacology and Experimental Therapeutics. 323: 78-84. PMID 17636007 DOI: 10.1124/Jpet.107.123463  0.665
2007 Rondelli CM, Szasz IT, Kayal A, Thakali K, Watson RE, Rovner AS, Eddinger TJ, Fink GD, Watts SW. Preferential myosin heavy chain isoform B Expression may contribute to the faster velocity of contraction in veins versus arteries. Journal of Vascular Research. 44: 264-72. PMID 17377397 DOI: 10.1159/000100991  0.73
2007 Ni W, Fink GD, Watts SW. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension. The Journal of Pharmacology and Experimental Therapeutics. 321: 485-91. PMID 17289838 DOI: 10.1124/Jpet.106.114017  0.61
2007 Watts SW, Rondelli C, Thakali K, Li X, Uhal B, Pervaiz MH, Watson RE, Fink GD. Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats. American Journal of Physiology. Heart and Circulatory Physiology. 292: H2438-48. PMID 17237246 DOI: 10.1152/Ajpheart.00900.2006  0.702
2007 Szasz T, Thakali K, Fink GD, Watts SW. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. Experimental Biology and Medicine (Maywood, N.J.). 232: 27-37. PMID 17202583 DOI: 10.3181/00379727-207-2320027  0.661
2007 Thakali K, Davenport L, Fink GD, Watts SW. Cyclooxygenase, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase MAPK, Rho kinase, and Src mediate hydrogen peroxide-induced contraction of rat thoracic aorta and vena cava. The Journal of Pharmacology and Experimental Therapeutics. 320: 236-43. PMID 17003231 DOI: 10.1124/Jpet.106.110650  0.702
2007 Priestley JR, Ni W, Watts S. Endogenous serotonin potentiates norepinephrine‐induced contraction of the superior mesenteric artery The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A517-B  0.58
2007 Thakali K, Galligan JJ, Fink GD, Gariepy CE, Watts SW. Endothelin (ET) receptor interaction does not occur in vena cava from ET B receptor deficient rats The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A517-A  0.686
2007 Thakali KM, Galligan JJ, Fink GD, Watts SW. Arterial and Venous Function in Hypertension Comprehensive Hypertension. 205-212. DOI: 10.1016/B978-0-323-03961-1.50022-2  0.689
2006 Ogden K, Thompson JM, Hickner Z, Huang T, Tang DD, Watts SW. A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction. American Journal of Physiology. Heart and Circulatory Physiology. 291: H2857-63. PMID 16861698 DOI: 10.1152/Ajpheart.00229.2006  0.305
2006 Thakali KM, Lau Y, Fink GD, Galligan JJ, Chen AF, Watts SW. Mechanisms of hypertension induced by nitric oxide (NO) deficiency: focus on venous function. Journal of Cardiovascular Pharmacology. 47: 742-50. PMID 16810074 DOI: 10.1097/01.Fjc.0000211789.37658.E4  0.749
2006 Ni W, Watts SW. 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clinical and Experimental Pharmacology & Physiology. 33: 575-83. PMID 16789923 DOI: 10.1111/J.1440-1681.2006.04410.X  0.47
2006 Ni W, Lookingland K, Watts SW. Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and Nomega-nitro-L-arginine but not spontaneously hypertensive rats. Hypertension. 48: 134-40. PMID 16754787 DOI: 10.1161/01.Hyp.0000225754.15146.Dd  0.593
2006 Thakali K, Davenport L, Fink GD, Watts SW. Pleiotropic effects of hydrogen peroxide in arteries and veins from normotensive and hypertensive rats. Hypertension. 47: 482-7. PMID 16432037 DOI: 10.1161/01.Hyp.0000201540.91234.8F  0.716
2006 Ni W, Lookingland K, Watts SW. Response to blood pressure in mutant rats lacking the 5-hydroxytryptamine transporter [8] Hypertension. 48: e117. DOI: 10.1161/01.Hyp.0000246309.64175.69  0.52
2005 Xu H, Bian X, Watts SW, Hlavacova A. Activation of vascular BK channel by tempol in DOCA-salt hypertensive rats. Hypertension. 46: 1154-62. PMID 16216988 DOI: 10.1161/01.Hyp.0000186278.50275.Fa  0.35
2005 Northcott CA, Hayflick J, Watts SW. Upregulated function of phosphatidylinositol-3-kinase in genetically hypertensive rats: a moderator of arterial hypercontractility. Clinical and Experimental Pharmacology & Physiology. 32: 851-8. PMID 16173947 DOI: 10.1111/J.1440-1681.2010.04276.X  0.77
2005 Thakali K, Demel SL, Fink GD, Watts SW. Endothelin-1-induced contraction in veins is independent of hydrogen peroxide. American Journal of Physiology. Heart and Circulatory Physiology. 289: H1115-22. PMID 15908460 DOI: 10.1152/Ajpheart.00086.2005  0.66
2005 Ni W, Wilhelm CS, Bader M, Murphy DL, Lookingland K, Watts SW. (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 314: 953-60. PMID 15901794 DOI: 10.1124/Jpet.105.087080  0.531
2005 Wang H, Chen AF, Watts SW, Galligan JJ, Fink GD. Endothelin in the splanchnic vascular bed of DOCA-salt hypertensive rats. American Journal of Physiology. Heart and Circulatory Physiology. 288: H729-36. PMID 15471983 DOI: 10.1152/Ajpheart.00388.2004  0.424
2005 Atkins KB, Northcott CA, Watts SW, Brosius FC. Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries. American Journal of Physiology. Heart and Circulatory Physiology. 288: H235-43. PMID 15345487 DOI: 10.1152/Ajpheart.00643.2004  0.767
2005 KAYAL A, THAKALI K, RONDELLI C, WATSON R, ROVNER A, FINK G, WATTS S. Myosin heavy chain B isoform is more predominant in rat veins than arteries American Journal of Hypertension. 18: A15-A15. DOI: 10.1016/J.Amjhyper.2005.03.036  0.706
2004 Ni W, Thompson JM, Northcott CA, Lookingland K, Watts SW. The serotonin transporter is present and functional in peripheral arterial smooth muscle. Journal of Cardiovascular Pharmacology. 43: 770-81. PMID 15167270 DOI: 10.1097/00005344-200406000-00006  0.79
2004 Slovut DP, Mehta SH, Dorrance AM, Brosius FC, Watts SW, Webb RC. Increased vascular sensitivity and connexin43 expression after sympathetic denervation. Cardiovascular Research. 62: 388-96. PMID 15094358 DOI: 10.1016/J.Cardiores.2003.12.024  0.318
2004 Thakali K, Fink GD, Watts SW. Arteries and veins desensitize differently to endothelin. Journal of Cardiovascular Pharmacology. 43: 387-93. PMID 15076222 DOI: 10.1097/00005344-200403000-00009  0.712
2004 Dai X, Galligan JJ, Watts SW, Fink GD, Kreulen DL. Increased O2*- production and upregulation of ETB receptors by sympathetic neurons in DOCA-salt hypertensive rats. Hypertension. 43: 1048-54. PMID 15051669 DOI: 10.1161/01.Hyp.0000126068.27125.42  0.308
2004 Northcott CA, Hayflick JS, Watts SW. PI3-kinase upregulation and involvement in spontaneous tone in arteries from DOCA-salt rats: is p110delta the culprit? Hypertension. 43: 885-90. PMID 14993194 DOI: 10.1161/01.Hyp.0000118518.20331.E8  0.764
2004 Wehrwein EA, Northcott CA, Loberg RD, Watts SW. Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension. The Journal of Pharmacology and Experimental Therapeutics. 309: 1011-9. PMID 14982964 DOI: 10.1124/Jpet.103.062265  0.712
2004 Ni W, Li MW, Thakali K, Fink GD, Watts SW. The fenfluramine metabolite (+)-norfenfluramine is vasoactive. The Journal of Pharmacology and Experimental Therapeutics. 309: 845-52. PMID 14752059 DOI: 10.1124/Jpet.103.060806  0.776
2004 Watts SW, Thompson JM. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat. The Journal of Pharmacology and Experimental Therapeutics. 309: 165-72. PMID 14724222 DOI: 10.1124/jpet.103.062562  0.319
2004 Northcott CA, Watts SW. Low [Mg2+]e enhances arterial spontaneous tone via phosphatidylinositol 3-kinase in DOCA-salt hypertension. Hypertension. 43: 125-9. PMID 14638620 DOI: 10.1161/01.Hyp.0000103631.68328.03  0.71
2003 Banes AK, Watts SW. Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension. Bmc Pharmacology. 3: 12. PMID 12974983 DOI: 10.1186/1471-2210-3-12  0.811
2003 Li L, Watts SW, Banes AK, Galligan JJ, Fink GD, Chen AF. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension. Hypertension. 42: 316-21. PMID 12885792 DOI: 10.1161/01.Hyp.0000084853.47326.F2  0.816
2003 Loberg RD, Northcott CA, Watts SW, Brosius FC. PI3-kinase-induced hyperreactivity in DOCA-salt hypertension is independent of GSK-3 activity. Hypertension. 41: 898-902. PMID 12629035 DOI: 10.1161/01.Hyp.0000061762.58873.2F  0.744
2003 Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ, Chen AF. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation. 107: 1053-8. PMID 12600921 DOI: 10.1161/01.Cir.0000051459.74466.46  0.771
2002 Russell A, Banes A, Berlin H, Fink GD, Watts SW. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat. The Journal of Pharmacology and Experimental Therapeutics. 303: 179-87. PMID 12235249 DOI: 10.1124/Jpet.102.037390  0.812
2002 Northcott CA, Poy MN, Najjar SM, Watts SW. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circulation Research. 91: 360-9. PMID 12193470 DOI: 10.1161/01.Res.0000030861.13850.F1  0.754
2002 Watts SW, Fink GD, Northcott CA, Galligan JJ. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists. British Journal of Pharmacology. 137: 69-79. PMID 12183332 DOI: 10.1038/Sj.Bjp.0704831  0.753
2002 Johnson RJ, Fink GD, Watts SW, Galligan JJ. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats. Journal of Hypertension. 20: 665-76. PMID 11910302 DOI: 10.1097/00004872-200204000-00024  0.46
2002 Watts SW. Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension. Hypertension. 39: 825-9. PMID 11897772 DOI: 10.1161/hy0302.104668  0.454
2002 Banes AK, Watts SW. Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension. Hypertension. 39: 394-8. PMID 11882579  0.806
2001 Northcott C, Florian JA, Dorrance A, Watts SW. Arterial epidermal growth factor receptor expression in deoxycorticosterone acetate-salt hypertension Hypertension. 38: 1337-1341. PMID 11751714 DOI: 10.1161/Hy1201.096815  0.751
2001 Banes AK, Loberg RD, Brosius FC, Watts SW. Inability of serotonin to activate the c-Jun N-terminal kinase and p38 kinase pathways in rat aortic vascular smooth muscle cells. Bmc Pharmacology. 1: 8. PMID 11667949 DOI: 10.1186/1471-2210-1-8  0.786
2001 Banes AK, Watts SW. Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat. Hypertension. 38: 891-5. PMID 11641304  0.821
2001 Watts SW, Yang P, Banes AK, Baez M. Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors. Journal of Cardiovascular Pharmacology. 38: 539-51. PMID 11588524 DOI: 10.1097/00005344-200110000-00006  0.79
2001 Atkins KB, Johns D, Watts S, Webb RC, Brosius FC. Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension. Journal of Hypertension. 19: 1581-1587. PMID 11564977 DOI: 10.1097/00004872-200109000-00009  0.433
2001 Florian JA, Dorrance A, Webb RC, Watts SW. Mineralocorticoids upregulate arterial contraction to epidermal growth factor American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 281. PMID 11507004 DOI: 10.1152/Ajpregu.2001.281.3.R878  0.341
2000 Watts SW, Harris B. Is functional upregulation of the 5-HT2B receptor in deoxycorticosterone acetate salt-treated rats blood pressure dependent? General Pharmacology. 33: 439-47. PMID 10647769 DOI: 10.1016/S0306-3623(99)00040-3  0.439
2000 Watts SW. 5-Hydroxytryptamine-induced potentiation of endothelin-1- and norepinephrine-induced contraction is mitogen-activated protein kinase pathway dependent. Hypertension (Dallas, Tex. : 1979). 35: 244-8. PMID 10642305 DOI: 10.1161/01.HYP.35.1.244  0.374
1999 Florian JA, Watts SW. Epidermal growth factor: A potent vasoconstrictor in experimental hypertension American Journal of Physiology - Heart and Circulatory Physiology. 276. PMID 10070082 DOI: 10.1152/ajpheart.1999.276.3.H976  0.33
1999 Watts SW, Fink GD. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats. The American Journal of Physiology. 276: H944-52. PMID 10070078 DOI: 10.1152/Ajpheart.1999.276.3.H944  0.446
1998 Watts SW. The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension. Journal of Hypertension. 16: 811-22. PMID 9663921 DOI: 10.1097/00004872-199816060-00012  0.377
1996 Watts SW, Webb RC. Vascular gap junctional communication is increased in mineralocorticoid-salt hypertension. Hypertension (Dallas, Tex. : 1979). 28: 888-93. PMID 8901840 DOI: 10.1161/01.HYP.28.5.888  0.362
1996 Watts SW, Yeum CH, Campbell G, Webb RC. Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase. Journal of Vascular Research. 33: 288-98. PMID 8695753 DOI: 10.1159/000159156  0.355
1996 Watts SW, Gilbert L, Webb RC. 5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats. Hypertension (Dallas, Tex. : 1979). 26: 1056-9. PMID 7498967 DOI: 10.1161/01.HYP.26.6.1056  0.45
1995 Watts SW, Traub O, Webb RC. Effects of ramipril on contractile oscillations in arteries from genetically hypertensive rats. Clinical and Experimental Hypertension (New York, N.Y. : 1993). 16: 881-98. PMID 7532066 DOI: 10.3109/10641969409078032  0.363
1994 Watts SW, Traub O, Lamb FS, Myers JH, Webb RC. Effect of ramipril on alpha-adrenoceptor-mediated oscillatory contractions in tail artery of hypertensive rats. European Journal of Pharmacology. 242: 245-53. PMID 8281989 DOI: 10.1016/0014-2999(93)90248-G  0.312
1994 Watts SW, Finta KM, Lloyd MC, Storm DS, Webb RC. Enhanced vascular responsiveness to Bay K 8644 in mineralocorticoid- and N-nitro arginine-induced hypertension. Blood Pressure. 3: 340-8. PMID 7532526 DOI: 10.3109/08037059409102284  0.339
Show low-probability matches.